Liraglutide Injection Market By Type ( Type-a, Type-b ), By Application ( Hypoglycemia, Obesity, Diabetes ), Industry Trends, Estimation & Forecast, 2017 - 2025

Check Today's Best Price

$3500 Buy Now
Liraglutide Injection Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.
  • Market Overview:

    Liraglutide is an analog of human incretin (metabolic hormone) glucagon-like peptide-1 (GLP-1) which is highly efficient when used as a long-acting glucagon-like peptide-1 receptor agonist. This metabolic hormone analog is highly efficient in controlling the complications related to type-2 diabetes as it increases the metabolism of the body by significantly lowering the glucose levels and by binding with the same receptors as done by GLP-1. This medicinal injection is sold under the brand name of Victoza. The laraglutide market is in its nascent stage of development, as the traditional insulin analog is still prevalent among the patients, globally. Moreover, the injection is only approved in very few regions such as the US, Europe and Japan. The European Medicines Agency has recently approved liraglutide, for adults with a body mass index (BMI) of 30. However, apart from its benefits, liraglutide has various side effects as well. Various tests done on animals have revealed that improper or over dosage of liraglutide might result in the occurrence if tumors in thyroid glands. On the other hand, continuously rising number of diabetic patients who are simultaneously dealing with obesity as well, is expected to bring future growth opportunities for the very market in the near future. As per the data revealed by Centers for Disease Control and Prevention (CDC), diabetes has affected more than 20 million people in the U.S. alone and the number is anticipated to reach 30 million by 2030.

    The report provides detailed qualitative and quantitative analysis of the Global Liraglutide Injection Market. Market size and forecast in terms of value and volume has been provided for the period – (2017 – 2025), for the segments namely type and application in each of the major regions.

    Liraglutide Injection Market Segmentation

    By Type
    • Type-a
    • Type-b

    By Application
    • Hypoglycemia
    • Obesity
    • Diabetes
    • Others

    By Geography

    • North America
    o U.S.
    o Canada
    o Mexico

    • Europe
    o U.K.
    o France
    o Germany
    o Italy
    o Spain
    o Rest of Europe

    • Asia-Pacific
    o China
    o Japan
    o India
    o Korea
    o Rest of APAC

    • South America
    o Brazil
    o Rest of South America

    • Rest of the World
    o Middle East
    o Africa

    keyboard_arrow_up
  • CHAPTER 1. INTRODUCTION
    1.1. RESEARCH METHODOLOGY
    1.1.1. ERC desk research
    1.1.2. ERC data synthesis
    1.1.3. Data validation and market feedback
    1.1.4. ERC data sources

    CHAPTER 2. LIRAGLUTIDE INJECTION MARKET OVERVIEW
    2.1. LIRAGLUTIDE INJECTION MARKET INTRODUCTION
    2.2. GLOBAL LIRAGLUTIDE INJECTION MARKET PRODUCTION AND GROWTH RATE, 2017-2025
    2.2.1. Global Liraglutide Injection Production (VOLUME) and Growth Rate (%), (2017-2025)
    2.3. GLOBAL LIRAGLUTIDE INJECTION MARKET CAPACITY AND GROWTH RATE, 2017-2025
    2.3.1. Global Liraglutide Injection Capacity (VOLUME) and Growth Rate (%), (2017-2025)
    2.4. GLOBAL LIRAGLUTIDE INJECTION MARKET REVENUE AND GROWTH RATE, 2017-2025
    2.4.1. Global Liraglutide Injection Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
    2.5. GLOBAL LIRAGLUTIDE INJECTION MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
    2.5.1. Global Liraglutide Injection Consumption (VOLUME) and Growth Rate (%), (2017-2025)
    2.6. GLOBAL LIRAGLUTIDE INJECTION MARKET PRICE TREND, 2017-2025
    2.6.1. Global Liraglutide Injection Market Price Trend and Growth Rate (%), (2017-2025)

    CHAPTER 3. GLOBAL LIRAGLUTIDE INJECTION MARKET BY TYPE, 2017-2025
    3.1. TYPE-A
    3.2. TYPE-B
    3.3. GLOBAL LIRAGLUTIDE INJECTION MARKET REVENUE BY TYPE, 2017-2025
    3.3.1. Global Liraglutide Injection Market Revenue (Million USD) and Share (%) By Type, 2017-2025
    3.3.2. Type-a Market Revenue and Growth Rate, 2017-2025
    3.3.3. Type-b Market Revenue and Growth Rate, 2017-2025
    3.4. GLOBAL LIRAGLUTIDE INJECTION MARKET PRODUCTION BY TYPE, 2017-2025
    3.4.1. Global Liraglutide Injection Market Production (Volume) and Share (%) By Type, 2017-2025
    3.4.2. Type-a Market Production and Growth Rate, 2017-2025
    3.4.3. Type-b Market Production and Growth Rate, 2017-2025

    CHAPTER 4. GLOBAL LIRAGLUTIDE INJECTION MARKET BY APPLICATION, 2017-2025
    4.1. HYPOGLYCEMIA
    4.2. OBESITY
    4.3. DIABETES
    4.4. GLOBAL LIRAGLUTIDE INJECTION MARKET REVENUE BY APPLICATION, 2017-2025
    4.4.1. Global Liraglutide Injection Market Revenue (Million USD) and Share (%) By Application, 2017-2025
    4.4.2. Hypoglycemia Market Revenue and Growth Rate, 2017-2025
    4.4.3. Obesity Market Revenue and Growth Rate, 2017-2025
    4.4.4. Diabetes Market Revenue and Growth Rate, 2017-2025
    4.5. GLOBAL LIRAGLUTIDE INJECTION MARKET CONSUMPTION BY APPLICATION, 2017-2025
    4.5.1. Global Liraglutide Injection Market Consumption (Volume) and share (%) By Application, 2017-2025
    4.5.2. Hypoglycemia Market Consumption and Growth Rate, 2017-2025
    4.5.3. Obesity Market Consumption and Growth Rate, 2017-2025
    4.5.4. Diabetes Market Consumption and Growth Rate, 2017-2025

    Note: Similar information coverage has been provided for other application segment.

    CHAPTER 5. GLOBAL LIRAGLUTIDE INJECTION MARKET BY REGION, 2017-2025
    5.1. NORTH AMERICA
    5.1.1. U.S.
    5.1.2. Canada
    5.1.3. Mexico
    5.2. EUROPE
    5.2.1. U.K.
    5.2.2. France
    5.2.3. Germany
    5.2.4. Italy
    5.2.5. Spain
    5.2.6. Rest of Europe
    5.3. ASIA PACIFIC
    5.3.1. China
    5.3.2. Japan
    5.3.3. India
    5.3.4. Korea
    5.3.5. Rest of APAC
    5.4. SOUTH AMERICA
    5.4.1. Brazil
    5.4.2. Rest of South America
    5.5. REST OF THE WORLD
    5.5.1. Middle East
    5.5.2. Africa
    5.6. GLOBAL LIRAGLUTIDE INJECTION MARKET REVENUE BY REGION, 2017-2025
    5.6.1. Global Liraglutide Injection Market Revenue (Million USD) and Share (%) By Region, 2017-2025
    5.6.2. North America Market Revenue and Growth Rate, 2017-2025
    5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
    5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
    5.6.5. South America Market Revenue and Growth Rate, 2017-2025
    5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025

    CHAPTER 6. GLOBAL LIRAGLUTIDE INJECTION MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
    6.1. GLOBAL LIRAGLUTIDE INJECTION MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
    6.1.1. Global Liraglutide Injection Market Production (Volume) and Share (%) By Region, 2017-2025
    6.1.2. Global Liraglutide Injection Market Consumption (Volume) and Share (%) By Region, 2017-2025
    6.1.3. North America Market Production and Consumption, 2017-2025
    6.1.4. Europe Market Production and Consumption, 2017-2025
    6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
    6.1.6. South America Market Production and Consumption, 2017-2025
    6.1.7. Rest of the World Market Production and Consumption, 2017-2025

    CHAPTER 7. MARKET DETERMINANTS
    7.1. MARKET DRIVERS
    7.2. MARKET RESTRAINTS
    7.3. MARKET OPPORTUNITIES
    7.4. MARKET DETERMINANTS RADAR CHART

    CHAPTER 8. GLOBAL LIRAGLUTIDE INJECTION MARKET COMPETITION BY MANUFACTURERS
    8.1. GLOBAL LIRAGLUTIDE INJECTION PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
    8.1.1. Global Liraglutide Injection Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
    8.2. GLOBAL LIRAGLUTIDE INJECTION REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
    8.2.1. Global Liraglutide Injection Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
    8.3. LIRAGLUTIDE INJECTION MARKET COMPETITIVE SITUATION AND TRENDS
    8.3.1. Liraglutide Injection Market Share (%) of Top 3 Manufacturers
    8.3.2. Liraglutide Injection Market Share (%) of Top 5 Manufacturers

    CHAPTER 9. GLOBAL LIRAGLUTIDE INJECTION MANUFACTURERS ANALYSIS
    9.1. COMPANY-A
    9.1.1. Business Overview
    9.1.2. Company Basic Information
    9.1.3. Liraglutide Injection Product Details
    9.1.4. Company-A Liraglutide Injection Production, Revenue and Gross Margin
    9.2. COMPANY-B
    9.2.1. Business Overview
    9.2.2. Company Basic Information
    9.2.3. Liraglutide Injection Product Details
    9.2.4. Company-B Liraglutide Injection Production, Revenue and Gross Margin
    9.3. COMPANY-C
    9.3.1. Business Overview
    9.3.2. Company Basic Information
    9.3.3. Liraglutide Injection Product Details
    9.3.4. Company-C Liraglutide Injection Production, Revenue and Gross Margin
    9.4. COMPANY-D
    9.4.1. Business Overview
    9.4.2. Company Basic Information
    9.4.3. Liraglutide Injection Product Details
    9.4.4. Company-D Liraglutide Injection Production, Revenue and Gross Margin
    9.5. COMPANY-E
    9.5.1. Business Overview
    9.5.2. Company Basic Information
    9.5.3. Liraglutide Injection Product Details
    9.5.4. Company-E Liraglutide Injection Production, Revenue and Gross Margin

    CHAPTER 10. LIRAGLUTIDE INJECTION MARKET VALUE CHAIN ANALYSIS
    10.1. LIRAGLUTIDE INJECTION INDUSTRIAL CHAIN ANALYSIS
    10.2. LIRAGLUTIDE INJECTION KEY RAW MATERIALS ANALYSIS
    10.2.1. Key Raw Materials
    10.2.2. Price Trend of Key Raw Materials
    10.2.3. Key Suppliers of Raw Materials
    10.3. MARKETING CHANNEL
    10.3.1. Direct Marketing
    10.3.2. Indirect Marketing
    10.3.3. Distributors/Traders
    10.4. CONSUMER ANALYSIS
    10.4.1. Consumer 1
    10.4.2. Consumer 2
    10.4.3. Consumer 3
    10.4.4. Consumer 4

    keyboard_arrow_up
  • • Company-A
    • Company-B
    • Company-C
    • Company-D
    • Company-E

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

• What was the market size of the Liraglutide Injection Market in 2017 and the expected market size by 2025, along with the growth rate?
• An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
• Which are the largest revenue generating products, services or regions and their comparative growth rate?
• Which technology is in trend and how would it evolve during the forecast period (2017 – 2025)?
• Which are the leading companies in the Liraglutide Injection Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

You may also like

CLIENTS

SHARE YOUR CART